Ruboxistaurin-d6 Hydrochloride
| Product Name |
Ruboxistaurin-d6 Hydrochloride
|
| Product Code |
DA-R101-a
|
| Chemical name |
Ruboxistaurin-d6 Hydrochloride
|
| Synonyms |
(9S)-9-[[(Dimethyl-d6)amino]methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-Dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione Hydrochloride; LY 333531-d6;
|
| Impurity |
NA
|
| CAS Number |
1794767-04-6
|
| Alternate CAS # |
NA
|
| Molecular form |
C28H23D6ClN4O3
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
511.04
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
amines,heterocycles,enzyme inhibitors,stable isotopes,pharmaceutical standards,intermediates,fine chemicals
|
| Boiling Point |
NA
|
| Applications |
Labelled Ruboxistaurin. Ruboxistaurin is a protein kinase C (PKC) β inhibitor, exhibits significant anti-angiogenic activity that reduces the response of vascular endothelial cells to stimulation by vascular endothelial growth factor (VEGF). Ruboxistaurin is used in treatment of diabetic microvascular complications.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
